Clinical Trial Update: A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating hydroxychloroquine in combination with gemcitabine and Abraxane in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Advanced Adenocarcinoma, Metastatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED